<VariationArchive VariationID="35905" VariationName="NM_000088.4(COL1A1):c.1812del (p.Gly605fs)" VariationType="Deletion" Accession="VCV000035905" Version="12" RecordType="classified" NumberOfSubmissions="6" NumberOfSubmitters="6" DateLastUpdated="2024-07-29" DateCreated="2013-04-04" MostRecentSubmission="2024-04-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="44569" VariationID="35905">
      <GeneList>
        <Gene Symbol="COL1A1" FullName="collagen type I alpha 1 chain" GeneID="1277" HGNC_ID="HGNC:2197" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q21.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="50184101" stop="50201631" display_start="50184101" display_stop="50201631" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="48261456" stop="48278999" display_start="48261456" display_stop="48278999" Strand="-" />
          </Location>
          <OMIM>120150</OMIM>
          <Haploinsufficiency last_evaluated="2012-08-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL1A1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-08-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL1A1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000088.4(COL1A1):c.1812del (p.Gly605fs)</Name>
      <CanonicalSPDI>NC_000017.11:50193002:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q21.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="50193003" stop="50193003" display_start="50193003" display_stop="50193003" variantLength="1" positionVCF="50193002" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="48270364" stop="48270364" display_start="48270364" display_stop="48270364" variantLength="1" positionVCF="48270363" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>G605fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.48270364del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.48270364del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.50193003del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.50193003del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007400.1" sequenceAccession="NG_007400" sequenceVersion="1" change="g.13637del">
            <Expression>NG_007400.1:g.13637del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000088.4" sequenceAccession="NM_000088" sequenceVersion="4" change="c.1812del" MANESelect="true">
            <Expression>NM_000088.4:c.1812del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000079.2" sequenceAccession="NP_000079" sequenceVersion="2" change="p.Gly605fs">
            <Expression>NP_000079.2:p.Gly605fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1" sequenceAccession="LRG_1">
            <Expression>LRG_1:g.13637del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000088.3" sequenceAccession="NM_000088" sequenceVersion="3" change="c.1812delT">
            <Expression>NM_000088.3:c.1812delT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1t1" sequenceAccession="LRG_1t1">
            <Expression>LRG_1t1:c.1812del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000088.4" sequenceAccession="NM_000088" sequenceVersion="4" change="c.1812delT" MANESelect="true">
            <Expression>NM_000088.4:c.1812delT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA260283" DB="ClinGen" />
        <XRef Type="rs" ID="193922143" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000088.4(COL1A1):c.1812del (p.Gly605fs) AND Osteogenesis imperfecta" Accession="RCV000029560" Version="2">
        <ClassifiedConditionList TraitSetID="5689">
          <ClassifiedCondition DB="MedGen" ID="C0029434">Osteogenesis imperfecta</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2011-08-18" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000088.4(COL1A1):c.1812del (p.Gly605fs) AND Osteogenesis imperfecta type I" Accession="RCV001807741" Version="8">
        <ClassifiedConditionList TraitSetID="5688">
          <ClassifiedCondition DB="MedGen" ID="C0023931">Osteogenesis imperfecta type I</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-03-30" SubmissionCount="3">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000088.4(COL1A1):c.1812del (p.Gly605fs) AND Osteogenesis imperfecta type III" Accession="RCV002470719" Version="2">
        <ClassifiedConditionList TraitSetID="5676">
          <ClassifiedCondition DB="MedGen" ID="C0268362">Osteogenesis imperfecta type III</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-05-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000088.4(COL1A1):c.1812del (p.Gly605fs) AND COL1A1-related disorder" Accession="RCV004549389" Version="1">
        <ClassifiedConditionList TraitSetID="80809">
          <ClassifiedCondition>COL1A1-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-11-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-03-30" NumberOfSubmissions="6" NumberOfSubmitters="6" DateCreated="2013-04-04" MostRecentSubmission="2024-04-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12362985</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16705691</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22206639</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27509835</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7942841</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9295084</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9443882</ID>
        </Citation>
        <DescriptionHistory Dated="2022-01-14">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="5688" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5697" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Lobstein disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Osteogenesis imperfecta type I</ElementValue>
                <XRef ID="Osteogenesis+imperfecta+type+1/5454" DB="Genetic Alliance" />
                <XRef ID="385482004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">OI type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta tarda</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta with blue sclerae</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lobstein's Disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta type 1A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta with opalescent teeth</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OI type 1A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta type 1 with dentinogenesis imperfecta</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OI, TYPE I</ElementValue>
                <XRef Type="MIM" ID="166200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta type 1</ElementValue>
                <XRef ID="MONDO:0008146" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OI1</ElementValue>
                <XRef Type="MIM" ID="166200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">COL1A1/2 osteogenesis imperfecta (COL1A1/2-OI) is characterized by fractures with minimal or absent trauma, variable dentinogenesis imperfecta (DI), and, in adult years, hearing loss. The clinical features of COL1A1/2-OI represent a continuum ranging from perinatal lethality to individuals with severe skeletal deformities, mobility impairments, and very short stature to nearly asymptomatic individuals with a mild predisposition to fractures, normal dentition, normal stature, and normal life span. Fractures can occur in any bone but are most common in the extremities. DI is characterized by gray or brown teeth that may appear translucent, wear down, and break easily. COL1A1/2-OI has been classified into four types based on clinical presentation and radiographic findings. This classification system can be helpful in providing information about prognosis and management for a given individual. The four more common OI types are now referred to as follows: Classic non-deforming OI with blue sclerae (previously OI type I). Perinatally lethal OI (previously OI type II). Progressively deforming OI (previously OI type III). Common variable OI with normal sclerae (previously OI type IV).</Attribute>
                <XRef ID="NBK1295" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000521190" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000260571" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000511197" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525779" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512698" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000332445" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000561718" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000562498" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8694" />
                <XRef ID="8694" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301472</ID>
                <ID Source="BookShelf">NBK1295</ID>
              </Citation>
              <Citation Type="general" Abbrev="EMQN, 2012">
                <ID Source="pmc">3234509</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2008">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_OsteogenesisImperfecta.pdf</URL>
                <CitationText>Orphanet Emergency Guidelines: Osteogenesis imperfecta (OI)</CitationText>
              </Citation>
              <XRef ID="216796" DB="Orphanet" />
              <XRef ID="666" DB="Orphanet" />
              <XRef ID="C0023931" DB="MedGen" />
              <XRef ID="MONDO:0008146" DB="MONDO" />
              <XRef Type="MIM" ID="166200" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5689" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6312" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Osteogenesis imperfecta</ElementValue>
                <XRef ID="Osteogenesis+imperfecta/5451" DB="Genetic Alliance" />
                <XRef ID="MONDO:0019019" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS166200" DB="OMIM" />
                <XRef ID="78314001" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OI</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1017" />
                <XRef ID="1017" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">COL1A1/2 osteogenesis imperfecta (COL1A1/2-OI) is characterized by fractures with minimal or absent trauma, variable dentinogenesis imperfecta (DI), and, in adult years, hearing loss. The clinical features of COL1A1/2-OI represent a continuum ranging from perinatal lethality to individuals with severe skeletal deformities, mobility impairments, and very short stature to nearly asymptomatic individuals with a mild predisposition to fractures, normal dentition, normal stature, and normal life span. Fractures can occur in any bone but are most common in the extremities. DI is characterized by gray or brown teeth that may appear translucent, wear down, and break easily. COL1A1/2-OI has been classified into four types based on clinical presentation and radiographic findings. This classification system can be helpful in providing information about prognosis and management for a given individual. The four more common OI types are now referred to as follows: Classic non-deforming OI with blue sclerae (previously OI type I). Perinatally lethal OI (previously OI type II). Progressively deforming OI (previously OI type III). Common variable OI with normal sclerae (previously OI type IV).</Attribute>
                <XRef ID="NBK1295" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301472</ID>
                <ID Source="BookShelf">NBK1295</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2006">
                <ID Source="pmc">3110960</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="pmc">3111019</ID>
              </Citation>
              <Citation Type="general" Abbrev="EMQN, 2012">
                <ID Source="pmc">3234509</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2008">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_OsteogenesisImperfecta.pdf</URL>
                <CitationText>Orphanet Emergency Guidelines: Osteogenesis imperfecta (OI)</CitationText>
              </Citation>
              <XRef ID="666" DB="Orphanet" />
              <XRef ID="C0029434" DB="MedGen" />
              <XRef ID="D010013" DB="MeSH" />
              <XRef ID="MONDO:0019019" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS166200" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="80809" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="66070" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">COL1A1-related disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">COL1A1-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">COL1A1-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="5676" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3679" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta type 3</ElementValue>
                <XRef ID="MONDO:0009804" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">OI type 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta, progressively deforming with normal sclerae</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OI type III</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Osteogenesis imperfecta type III</ElementValue>
                <XRef ID="Osteogenesis+imperfecta+type+3/5458" DB="Genetic Alliance" />
                <XRef ID="385483009" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OI3</ElementValue>
                <XRef Type="MIM" ID="259420" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">COL1A1</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8695" />
                <XRef ID="8695" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">COL1A1/2 osteogenesis imperfecta (COL1A1/2-OI) is characterized by fractures with minimal or absent trauma, variable dentinogenesis imperfecta (DI), and, in adult years, hearing loss. The clinical features of COL1A1/2-OI represent a continuum ranging from perinatal lethality to individuals with severe skeletal deformities, mobility impairments, and very short stature to nearly asymptomatic individuals with a mild predisposition to fractures, normal dentition, normal stature, and normal life span. Fractures can occur in any bone but are most common in the extremities. DI is characterized by gray or brown teeth that may appear translucent, wear down, and break easily. COL1A1/2-OI has been classified into four types based on clinical presentation and radiographic findings. This classification system can be helpful in providing information about prognosis and management for a given individual. The four more common OI types are now referred to as follows: Classic non-deforming OI with blue sclerae (previously OI type I). Perinatally lethal OI (previously OI type II). Progressively deforming OI (previously OI type III). Common variable OI with normal sclerae (previously OI type IV).</Attribute>
                <XRef ID="NBK1295" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301472</ID>
                <ID Source="BookShelf">NBK1295</ID>
              </Citation>
              <Citation Type="general" Abbrev="EMQN, 2012">
                <ID Source="pmc">3234509</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2008">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_OsteogenesisImperfecta.pdf</URL>
                <CitationText>Orphanet Emergency Guidelines: Osteogenesis imperfecta (OI)</CitationText>
              </Citation>
              <XRef ID="216812" DB="Orphanet" />
              <XRef ID="666" DB="Orphanet" />
              <XRef ID="C0268362" DB="MedGen" />
              <XRef ID="MONDO:0009804" DB="MONDO" />
              <XRef Type="MIM" ID="259420" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7694087" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="31519596|COL1A1-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004117864" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The COL1A1 c.1812delT variant is predicted to result in a frameshift and premature protein termination (p.Gly605Alafs*161). This variant was reported in two individuals from one family with osteogenesis imperfecta (Additional file 1, Swinnen et al 2011. PubMed ID: 22206639). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Frameshift variants in COL1A1 are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL1A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000088.3:c.1812delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">COL1A1-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4128851" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="4944209|MedGen:C0023931" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002113274" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">7942841</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9295084</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9443882</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22206639</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Gly605Alafs*161) in the COL1A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL1A1 are known to be pathogenic (PMID: 7942841, 9295084, 9443882). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with osteogenesis imperfecta (PMID: 22206639). ClinVar contains an entry for this variant (Variation ID: 35905). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL1A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.48270364del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0023931" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5414506" SubmissionDate="2022-12-21" DateLastUpdated="2022-12-24" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_000088_3_COL1A1_c_1812delT" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002769353" DateUpdated="2022-12-24" DateCreated="2022-12-24" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-05-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12362985</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16705691</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22206639</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27509835</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0103 - Dominant negative and loss of function are known mechanisms of disease in this gene and are associated with osteogenesis imperfecta (OI), types I-IV (MIM# 166200, MIM#166210, MIM#259420, MIM#166220), Caffey disease (MIM#114000) and arthrochalasia type Ehlers-Danlos syndrome 1 (MIM#130060). Variants resulting in a truncated protein are known to have a loss of function effect on protein, while missense variants affecting the G-X-Y of a triple helix motif, have a dominant negative effect (PMIDs:27509835, 12362985). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0701 â€“ Other NMD-predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. There are at least ten pathogenic NMD-predicted variants in ClinVar. (SP) 0802 - This variant has moderate previous evidence of pathogenicity in unrelated individuals. This variant has been reported in one individual with osteogenesis imperfecta (OI) and one family with OI and mixed hearing loss (ClinVar; PMIDs: 22206639, 16705691). (SP) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL1A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_3862</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000088.3:c.1812delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0009804" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_38</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4032875" SubmissionDate="2021-12-21" DateLastUpdated="2022-01-15" DateCreated="2022-01-15">
        <ClinVarSubmissionID localKey="NM_000088.3:c.1812del|OMIM:166200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002059239" DateUpdated="2022-01-15" DateCreated="2022-01-15" Type="SCV" Version="1" SubmitterName="Centogene AG  - the Rare Disease Company" OrgID="279559" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-05-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL1A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000088.3:c.1812del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="166200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10812468</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="56362" SubmissionDate="2011-08-18" DateLastUpdated="2022-03-28" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="COL1A1_1812delT_062111" title="COL1A1:c.1812delT and Osteogenesis Imperfecta" />
        <ClinVarAccession Accession="SCV000052212" DateUpdated="2022-03-28" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-08-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>likely pathogenic</GermlineClassification>
          <Comment>Converted during submission to Likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">autosomal unknown</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Tissue>Blood</Tissue>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <Purpose>assert pathogenicity</Purpose>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles">1</Attribute>
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Tissue>Blood</Tissue>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <Purpose>assert pathogenicity</Purpose>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles">1</Attribute>
            </ObservedData>
            <Co-occurrenceSet>
              <Zygosity>SingleHeterozygote</Zygosity>
              <AlleleDescSet>
                <Name>COL1A1:c.2560-18C&gt;G</Name>
                <Zygosity>SingleHeterozygote</Zygosity>
              </AlleleDescSet>
              <AlleleDescSet>
                <Name>COL1A1:c.4249-12G&gt;A</Name>
                <Zygosity>Homozygote</Zygosity>
              </AlleleDescSet>
              <AlleleDescSet>
                <Name>COL1A1:c.3223A&gt;G</Name>
                <Zygosity>Homozygote</Zygosity>
              </AlleleDescSet>
              <AlleleDescSet>
                <Name>COL1A1:c.299-20C&gt;G</Name>
                <Zygosity>Homozygote</Zygosity>
              </AlleleDescSet>
              <AlleleDescSet>
                <Name>COL1A2:c.3135C&gt;T</Name>
                <Zygosity>SingleHeterozygote</Zygosity>
              </AlleleDescSet>
              <AlleleDescSet>
                <Name>COL1A2:c.1665+15A&gt;G</Name>
                <Zygosity>SingleHeterozygote</Zygosity>
              </AlleleDescSet>
              <AlleleDescSet>
                <Name>COL1A2:c.937-3C&gt;T</Name>
                <Zygosity>Homozygote</Zygosity>
              </AlleleDescSet>
              <AlleleDescSet>
                <Name>COL1A2:c.936+14C&gt;T</Name>
                <Zygosity>Homozygote</Zygosity>
              </AlleleDescSet>
              <AlleleDescSet>
                <Name>COL1A2:c.1645C&gt;G</Name>
                <Zygosity>Homozygote</Zygosity>
              </AlleleDescSet>
              <Count>1</Count>
            </Co-occurrenceSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL1A1" />
          </GeneList>
          <VariantType>single nucleotide variant</VariantType>
          <MolecularConsequenceList>
            <MolecularConsequence Function="frameshift mutation">
              <XRef DB="Sequence Ontology" ID="SO:0000865" />
            </MolecularConsequence>
          </MolecularConsequenceList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000088.3:c.1812delT</Attribute>
          </AttributeSet>
          <AttributeSet>
            <Attribute Type="HGVS">p.Gly605AlafsX161</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Osteogenesis Imperfecta</ElementValue>
            </Name>
            <Symbol>
              <ElementValue Type="Preferred">OI</ElementValue>
            </Symbol>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4897070" SubmissionDate="2024-04-12" DateLastUpdated="2024-04-15" DateCreated="2022-04-28">
        <ClinVarSubmissionID localKey="rmh/unit_1/hg38_NM_000088_4_COL1A1_c_1812delT" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002503683" DateUpdated="2024-04-15" DateCreated="2022-04-28" Type="SCV" Version="2" SubmitterName="Molecular Genetics, Royal Melbourne Hospital" OrgID="508231" OrganizationCategory="laboratory" OrgAbbreviation="RMH" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>This sequence change is a deletion of 1 bp in exon 26 of 51 of COL1A1 that is predicted to create a premature termination codon at position 765 (p.Gly605Alafs*161). It is expected to result in an absent protein product through nonsense-mediated decay. Loss of function is an established mechanism of disease for this gene (PVS1). The variant is absent in a large population cohort (PM2; gnomAD v2.1 and v3). This variant is reported once as likely pathogenic in ClinVar (clinical details unavailable). Based on the classification scheme RMH ACMG Guidelines v1.2.1, this variant is classified as LIKELY PATHOGENIC. Following criteria are met: PVS1, PM2.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL1A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_3862</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000088.4:c.1812delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="166200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_12</SubmissionName>
          <SubmissionName>submission_41</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4897070" TraitType="Disease" MappingType="XRef" MappingValue="166200" MappingRef="OMIM">
        <MedGen CUI="C0023931" Name="Osteogenesis imperfecta type I" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7694087" TraitType="Disease" MappingType="Name" MappingValue="COL1A1-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="COL1A1-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="56362" TraitType="Disease" MappingType="Name" MappingValue="Osteogenesis Imperfecta" MappingRef="Preferred">
        <MedGen CUI="C0029434" Name="Osteogenesis imperfecta" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4128851" TraitType="Disease" MappingType="XRef" MappingValue="C0023931" MappingRef="MedGen">
        <MedGen CUI="C0023931" Name="Osteogenesis imperfecta type I" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5414506" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0009804" MappingRef="MONDO">
        <MedGen CUI="C0268362" Name="Osteogenesis imperfecta type III" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4032875" TraitType="Disease" MappingType="XRef" MappingValue="166200" MappingRef="OMIM">
        <MedGen CUI="C0023931" Name="Osteogenesis imperfecta type I" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

